Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Pharmaron Beijing Co., Ltd.
  6. Summary
    300759   CNE100003JW4

PHARMARON BEIJING CO., LTD.

(300759)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
09/10/2021 09/13/2021 09/14/2021 09/15/2021 09/16/2021 Date
195 192.52 204.88 210 210 Last
2746716 1529342 4547482 3976232 2845348 Volume
+1.57% -1.27% +6.42% +2.50% 0.00% Change
Estimated financial data (e)
Sales 2021 7 085 M 1 098 M 1 098 M
Net income 2021 1 461 M 226 M 226 M
Net cash position 2021 3 366 M 522 M 522 M
P/E ratio 2021 114x
Yield 2021 0,18%
Sales 2022 9 392 M 1 456 M 1 456 M
Net income 2022 2 015 M 312 M 312 M
Net cash position 2022 4 257 M 660 M 660 M
P/E ratio 2022 82,6x
Yield 2022 0,23%
Capitalization 166 B 25 784 M 25 807 M
EV / Sales 2021 23,0x
EV / Sales 2022 17,3x
Nbr of Employees -
Free-Float 71,1%
More Financials
Company
Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows: - laboratory services (63.3%); - manufacturing and control of chemistry (24.1%); - in vitro biology services (12.2%); Net sales are distributed geographically as follows: China (12.7%), Asia (4%), North America (58.8%),... 
More about the company
Ratings of Pharmaron Beijing Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about PHARMARON BEIJING CO., LTD.
08/29Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Half Year Ended ..
CI
07/15Pharmaron Beijing Co., Ltd. Provides Earnings Guidance for the Interim Period..
CI
06/20PHARMARON BEIJING : Files for Hong Kong Bourse Listing of Renminbi, US Dollar Bo..
MT
06/09PHARMARON BEIJING : Proposes Reduction of Registered Capital
MT
06/08Pharmaron Beijing Raising $600 Million From Sale of Renminbi, US Dollar Conve..
MT
05/31Pharmaron Beijing Co., Ltd. Approves Cash Dividend for the Year 2020, Payable..
CI
05/13MSCI Adds Ganfeng Lithium, Ningxia Baofeng to Global Emerging Markets Index U..
MT
04/30PHARMARON BEIJING : Closure of register of members for the first h shares class ..
PU
04/29PHARMARON BEIJING : First Quarter Profit Rockets 142%, Revenue Soars
MT
04/28PHARMARON BEIJING : Reply Slip for the First H Shares Class Meeting of 2021
PU
04/28PHARMARON BEIJING : Reply Slip for the Annual General Meeting of 2020 (Applicabl..
PU
04/28PHARMARON BEIJING : Form of Proxy for the First H Shares Class Meeting of 2021
PU
04/28PHARMARON BEIJING : Form of Proxy for the Annual General Meeting of 2020 (Applic..
PU
04/28PHARMARON BEIJING : Notice of the first h shares class meeting of 2021
PU
04/28PHARMARON BEIJING : Notice of the annual general meeting of 2020
PU
More news
News in other languages on PHARMARON BEIJING CO., LTD.
07/14PLANÈTE BOURSE  : La revue de presse du mercredi 14 juillet 2021
More news
Stock Trading Strategies
PHARMARON BEIJING CO., LTD. - 2020
Towards the breakout of a major resistance level
BUY
More Stock Trading Analysis
Chart PHARMARON BEIJING CO., LTD.
Duration : Period :
Pharmaron Beijing Co., Ltd. Technical Analysis Chart | 300759 | CNE100003JW4 | MarketScreener
Technical analysis trends PHARMARON BEIJING CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 210,00 CNY
Average target price 200,74 CNY
Spread / Average Target -4,41%
EPS Revisions
Managers and Directors
Bo Liang Lou Chairman & Chief Executive Officer
Shing Chung Li Chief Financial Officer & Board Secretary
Kexin Yang Chairman-Supervisory Board & Vice President
Hua Yang Chief Scientific Officer
Xiao Qiang Lou Chief Operating Officer & Executive Director
Sector and Competitors
1st jan.Capi. (M$)
PHARMARON BEIJING CO., LTD.74.42%24 534
MODERNA, INC.321.80%177 867
LONZA GROUP AG36.36%62 278
IQVIA HOLDINGS INC.43.91%49 407
CELLTRION, INC.-25.63%31 021
SEAGEN INC.-12.32%27 940